<DOC>
	<DOCNO>NCT00605735</DOCNO>
	<brief_summary>The purpose study find 300 mg BMS-582949 give daily effective placebo 12 week treatment subject rheumatoid arthritis also take methotrexate</brief_summary>
	<brief_title>PoC Rheumatoid Arthritis With Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Must diagnosis RA least 6 month Must take methotrexate least 3 month &amp; stable dose 7.530 mg weekly ) 4 week dose study medication Must least 6 swollen least 8 tender joint CRP upper limit normal ESR &gt; 28 mm/hr Must washout ( stop take ) immunosuppressant medication treat RA ( except methotrexate ) dose study medication Any infection include TB , HIV , Hepatitis B C Recent infection require antibiotic within 4 week History gastrointestinal disease ( GERD , gastrointestinal ulcer , heartburn ) require medical surgical treatment within 3 month Chronic use proton pump inhibitor ( Losec , Prilosec , Prevacid , Nexium ) , H2 blocker ( Tagamet , Pepcid , Zantac , Axid ) antacid ( Mylanta , Maalox )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>